Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Nuo Therapeutics, Inc. | CEO/CFO, Director | Common Stock | 1.98M | $988K | $0.50 | Nov 9, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AURX | Nuo Therapeutics, Inc. | Nov 9, 2022 | 9 | -$244K | 4 | Nov 14, 2022 | CEO/CFO, Director |
AURX | Nuo Therapeutics, Inc. | Apr 29, 2022 | 1 | $10.5K | 4 | May 2, 2022 | CEO/CFO, Director |
AURX | Nuo Therapeutics, Inc. | Mar 4, 2022 | 2 | $0 | 4 | Apr 26, 2022 | CEO/CFO, Director |
AURX | Nuo Therapeutics, Inc. | Dec 31, 2021 | 6 | $228K | 5 | Apr 26, 2022 | CEO/CFO, Director |
AURX | Nuo Therapeutics, Inc. | Dec 31, 2020 | 6 | $173K | 5 | Apr 26, 2022 | CEO/CFO, Director |
AURX | Nuo Therapeutics, Inc. | Dec 31, 2019 | 2 | $0 | 5 | Apr 26, 2022 | CEO/CFO, Director |